Colon Cancer Defeated: Drug with 100% Effectiveness Approved

The American FDA agency has declared Dostarlimab a breakthrough drug. During clinical trials, all patients were completely cured of colon cancer without the use of chemotherapy or surgery. The main advantage of Dostarlimab is that it completely destroys cancer and ensures sustained remission, eliminating the likelihood of the disease returning.